Testosterone Cream Dosing for Women
For adult women requiring testosterone therapy, start with 5 mg of testosterone cream applied daily to the upper arm, with serum testosterone monitoring at 2-3 months to guide dose titration up to 10 mg if needed. 1
Starting Dose and Application
- Begin with 5 mg testosterone cream applied once daily to dry, intact skin of the upper arm or torso 2, 1
- The 5 mg dose restores total testosterone and free testosterone levels to within or above the premenopausal reference range 1
- Apply to clean, dry skin and wash hands thoroughly after application to prevent unintended transfer to partners or children 2
Dose Titration
- If symptoms persist after 3 months on 5 mg, increase to 10 mg daily 1
- Note that doubling the dose from 5 mg to 10 mg produces only a 30-31% increase in testosterone levels, not a proportional doubling 1
- Evaluate treatment effect after 3-6 months and consider limiting therapy duration to 24 months given limited long-term safety data 3
Monitoring Schedule
- Check serum testosterone levels 2-3 months after initiating therapy or after any dose change 2
- Once stable therapeutic levels are confirmed, monitor every 6-12 months 2
- Testosterone concentrations can vary substantially with cream formulations, making monitoring essential to ensure appropriate levels 2
- Annual clinical review is recommended, with particular attention to treatment compliance 3
Application Site Considerations
- Primary application site: upper arms or shoulders 2, 1
- Alternative sites include chest or abdomen if needed, though absorption may vary by anatomical location 4
- Avoid application to areas with high risk of transfer (e.g., breasts, genitals) 2
Formulation Guidance
- Prescribe commercially manufactured testosterone products rather than compounded preparations when possible, as compounded products may have considerable variation in potency and quality 2
- Transdermal preparations offer the advantage of relatively stable day-to-day testosterone levels 2
Contraindications and Precautions
- Absolute contraindication: breast cancer survivors (HRT is generally contraindicated) 3
- Women with BRCA1/2 mutations without personal history of breast cancer may use testosterone therapy after prophylactic bilateral salpingo-oophorectomy 3
- Counsel patients about potential for skin-to-skin transfer to partners or children through direct contact 2
- Avoid progestins with anti-androgenic effects in women with iatrogenic premature ovarian insufficiency, as these may worsen hypoandrogenism and sexual dysfunction 3
Common Pitfalls
- Inadequate monitoring: Failing to check testosterone levels at 2-3 months can result in under- or over-dosing 2
- Assuming dose proportionality: Doubling the dose does not double testosterone levels; expect only 30% increases 1
- Transfer risk: Patients must understand proper hygiene measures to prevent unintended exposure to household contacts 2
- Using compounded products: These have unpredictable potency and should be avoided when commercial products are available 2